The dhr was reviewed for lot 21l0151 and indicated no abnormal processing.The lot in question met all specifications prior to its release.There have been no ncrs or capas associated with this lot.Ous flex fr ifu (p/n 40002-06-2) lists the following as a potential adverse effect: "extrusion or migration of the bone void filler, as is possible with any bone void filler, resulting in pain, neural impingement, physical impairment, irritation or wear of an articulating joint, or loss of function; any of which may require revision surgery".As such, no updates are required for the ifu.Based on the information gathered, there is no causal link between the flex fr product and the migration.As listed in the ifu (p/n 40002-06-2), migration is listed as a potential adverse effect.
|